Theratechnologies Inc.
TH.TO
TSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.90M | 3.09M | 987.00K | -4.48M | -2.76M |
| Total Depreciation and Amortization | 493.00K | 489.00K | 1.26M | 517.00K | 576.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.26M | 480.00K | 367.00K | 835.00K | 3.54M |
| Change in Net Operating Assets | -4.08M | 544.00K | -2.91M | 1.42M | -5.47M |
| Cash from Operations | -227.00K | 4.60M | -290.00K | -1.71M | -4.11M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 166.00K | 779.00K | -137.00K | 134.00K | 142.00K |
| Cash from Investing | 166.00K | 779.00K | -137.00K | 134.00K | 142.00K |
| Total Debt Issued | 45.00M | -- | -- | -- | 0.00 |
| Total Debt Repaid | -63.35M | -1.80M | -122.00K | -122.00K | -119.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 25.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -359.00K | -65.00K | -517.00K | -153.00K | -1.95M |
| Cash from Financing | -18.71M | -1.87M | -639.00K | -275.00K | 23.09M |
| Foreign Exchange rate Adjustments | -25.00K | 9.00K | -8.00K | -8.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.79M | 3.52M | -1.07M | -1.86M | 19.13M |
